BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 15895299)

  • 1. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
    Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
    Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
    Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
    Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy.
    Nishie M; Mori F; Yoshimoto M; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):546-54. PubMed ID: 15488031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
    Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
    Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy.
    Komori T; Ishizawa K; Arai N; Hirose T; Mizutani T; Oda M
    Acta Neuropathol; 2003 Jul; 106(1):66-70. PubMed ID: 12669242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
    Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
    Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
    Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
    Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial involvement in diffuse Lewy body disease.
    Terada S; Ishizu H; Yokota O; Tsuchiya K; Nakashima H; Ishihara T; Fujita D; Uéda K; Ikeda K; Kuroda S
    Acta Neuropathol; 2003 Feb; 105(2):163-9. PubMed ID: 12536227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
    Sebeo J; Hof PR; Perl DP
    Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.
    Pountney DL; Chegini F; Shen X; Blumbergs PC; Gai WP
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):74-9. PubMed ID: 15882793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies.
    Piao YS; Mori F; Hayashi S; Tanji K; Yoshimoto M; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2003 Apr; 105(4):403-9. PubMed ID: 12624794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease.
    Krim E; Vital A; Macia F; Yekhlef F; Tison F
    Mov Disord; 2005 Feb; 20(2):200-4. PubMed ID: 15382212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H; DelleDonne A; Uitti R; Dickson DW
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.